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ABSTRACT 
Amyloid deposition of wild-W\SH KXPDQ ȕ2-
microglobulin (WT-Kȕ2m) in the joints of long-term 
hemodialysis patients is the hallmark of dialysis-
related amyloidosis (DRA). In vitro, WT-Kȕ2m 
does not form amyloid fibrils at physiological pH 
and temperature unless co-solvents or other 
reagents are added. Therefore, understanding how 
fibril formation is initiated and maintained in the 
joint space is important for elucidating WT-Kȕ2m 
aggregation and DRA onset. Here, we investigated 
the roles of collagen I and the commonly 
administered anticoagulant, low-molecular-weight 
(LMW) heparin, in the initiation and subsequent 
aggregation phases of WT-Kȕ2m in physiologically 
relevant conditions. Using thioflavin T (ThT) 
fluorescence to study the kinetics of amyloid 
formation, we analyzed how these two agents affect 
specific stages of WT-Kȕ2m assembly. Our results 
revealed that LMW-heparin strongly promotes WT-
Kȕ2m fibrillogenesis during all stages of 
aggregation. However, collagen I affected WT-
Kȕ2m amyloid formation in contrasting ways: 
decreasing the lag time of fibril formation in the 
presence of LMW-heparin and slowing the rate at 
higher concentrations. We found that in self-seeded 
reactions, interaction of collagen I with WT-Kȕ2m 
amyloid fibrils attenuates surface-mediated growth 
of WT-hȕ2m fibrils, demonstrating a key role of 
secondary nucleation in WT-Kȕ2m amyloid 
formation. Interestingly, collagen I fibrils did not 
suppress surface-mediated assembly of WT-Kȕ2m 
monomers when cross-seeded with fibrils formed 
from the N-WHUPLQDOO\WUXQFDWHGYDULDQWǻ1-Kȕ2m. 
Together, these results provide detailed insights 
into how collagen I and LMW-heparin impact 
different stages in the aggregation of WT-hE2m into 
amyloid which lead to dramatic effects on the time 
course of assembly.  
 
 
Dialysis-related amyloidosis (DRA) is a severe 
condition that leads to progressive bone and joint 
atrophy in the majority of long-term haemodialysis 
patients(1-5). This disorder results from the 
deposition of amyloid plaques formed 
predominantly of wild-type human E2-
microglobulin (WT-hȕ2m) in joints and cartilage 
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tissue(3,6-8). In its non-pathogenic role, WT-hȕ2m 
constitutes the light chain of the major 
histocompatibility complex class I (MHC I), which 
functions in presenting antigens to T-cells(9). After 
dissociation from the MHC I complex, WT-Kȕ2m is 
normally degraded and excreted by the kidneys(10). 
In renal failure, the concentration of E2m in the 
plasma is increased up to >60-times in comparison 
with that of healthy individuals(3,6-8). Aggregation 
of WT-Kȕ2m then leads to the formation of amyloid 
plaques that are deposited almost exclusively in 
skeletal tissues(11), which are rich in extracellular 
matrix (ECM) components, including collagens and 
the glycosaminoglycans (GAGs) heparan sulfate 
and hyaluronic acid(12-15). The mechanism of 
recruitment of WT-Kȕ2m specifically to skeletal 
tissues is not fully understood, but ECM 
components, such as low molecular weight 
(LMW)-heparin (a GAG mimic, relevant here since 
this is given to all patients undergoing renal 
replacement therapy), apolipoprotein E and 
collagen, have been found to enhance WT-Kȕ2m 
aggregation in vitro(13,16-18). Amyloid fibrils 
have also been found associated with collagen 
fibrils in ex vivo deposits from DRA patients(13), 
and monomers of both WT-Kȕ2m and its natural 
proteolytic product, 'N6-hE2m, which lacks the N-
terminal six amino acids, have been shown to have 
weak (KD: 4.1×10í M and 4.9×10í M, 
respectively(15)) affinities for collagen I at the 
pathophysiologic pH of 6.4(12). Despite this 
evidence of the importance of LMW-heparin and 
collagen in amyloid formation, the mechanism(s) 
by which interactions with the reagents affect 
aggregation of WT-Kȕ2m and 'N6-hE2m remain 
unclear. 
 Compared with the intransigence of WT-Kȕ2m 
to form amyloid fibrils at pH 6-7(19,20), 'N6-hE2m 
readily forms amyloid at these pH values in 
vitro(21,22). 'N6-hE2m comprises ca. 30% of the 
hȕ2m present in DRA deposits(21,23) and contains 
a non-native trans-X-P32, a pre-requisite for 
amyloid formation(22,24) that is retained in the 
amyloid fibril structure itself(25). Weak 
interactions between the apical loops of 'N6-hE2m 
and WT-Kȕ2m have been shown to promote 
amyloid formation of the normally innocuous WT-
Kȕ2m (26,27), suggesting a potential role of 'N6-
hE2m in initiating fibril assembly of the WT protein. 
How 'N6-hE2m, collagen and LMW-heparin 
together influence amyloid formation of WT-hE2m, 
however, has remained unclear. 
 Here we used detailed analysis of the kinetics 
of amyloid formation to determine the role of 
collagen I, LMW-heparin and 'N6-hE2m, and their 
mixtures, on amyloid fibril formation of WT-Kȕ2m. 
The results reveal that LMW-heparin and collagen 
I influence multiple phases of WT-Kȕ2m amyloid 
formation, including initiation, elongation and 
secondary nucleation processes. Additionally, we 
found that the effects of collagen I on amyloid 
formation depend on whether fibril growth of WT-
hE2m is self-seeded or cross-seeded by 'N6-hE2m 
fibrils. Overall, the results shed new light on the 
mechanisms by which biologically-relevant factors 
influence WT-Kȕ2m amyloid assembly. More 
generally, they reveal how the local environment 
can have a dramatic effect in defining the rate and 
mechanisms of protein assembly into amyloid. 
 
RESULTS 
LMW-heparin and collagen I have a synergistic 
effect in the initiation of amyloid formation of 
WT-Kȕ2m 
The hallmark of DRA is formation of 
proteinaceous deposits comprised of WT-Kȕ2m and 
'N6-Kȕ2m in the ECM-rich joint spaces(3). As 
native WT-Kȕ2m does not form amyloid at neutral 
pH, or at the slightly acidified pH (pH 6.2) in 
affected joints(18), unless co-solvents or copper 
ions are added(13,16-19,28-32), (Figure 1A), we 
investigated how collagen I that is found in the 
ECM, and GAGs (represented by LMW-heparin), 
affect the kinetics of aggregation of WT-Kȕ2m. 
Previous studies have demonstrated a role of these 
FRPSRQHQWV LQ Kȕ2m amyloid 
assembly(13,15,17,18,33), but the precise 
mechanism(s) by which they affect aggregation, 
and the possible synergy between these different 
components, remained unclear. Using the 
enhancement of thioflavin T (ThT) fluorescence as 
a probe of amyloid formation and measurement of 
the resulting fibril growth kinetics showed that 
LMW-heparin (0.1 mg/ml) induces fibril formation 
of WT-Kȕ2m (0.47 mg/ml) within ~30 h, resulting 
in the formation of long, straight fibrils typical of 
amyloid (Figure 1A,B). By contrast, collagen I did 
not induce amyloid formation in the absence of 
LMW-heparin over the timescale measured here 
(Figure 1C,D) (note, however, that collagen can 
Extracellular matrix modulates E2m amyloid formation 
 
 
3 
promote amyloid fibril formation over much longer 
timescales, as previously reported(13)). Addition of 
both components revealed that collagen I modulates 
the kinetics of LMW-heparin-driven WT-Kȕ2m 
fibril formation in a complex manner (Figure 1E,F). 
At low concentrations (0.03-0.12 mg/ml), collagen 
I accelerates LMW-heparin-induced aggregation of 
WT-Kȕ2m, decreasing the lag time relative to the 
effect of LMW-heparin alone (Figure 1E, light 
green colours, compared with Figure 1A, blue). 
However, addition of higher concentrations of 
collagen I (0.47 mg/ml) in the presence of LMW-
heparin, retards fibril formation by increasing the 
lag time (Figure 1E, dark green colours, see also 
Supplemental Figure S1A). Enhancement of WT-
Kȕ2m amyloid formation by collagen I is consistent 
with previous results which have shown that 
collagen I alone can induce aggregation of WT-
Kȕ2m(13). WT-Kȕ2m has also been shown to bind to 
both collagen I and LMW-heparin(12,14,15,18). At 
high concentrations of collagen I, we assume that 
competition between collagen I and LMW-heparin 
binding to each other (KD: 7.9×10í M)(34) and 
binding to WT-Kȕ2m may reduce the availability of 
these components to interact with WT-Kȕ2m 
slowing its aggregation. Sequestration of WT-Kȕ2m 
nuclei/aggregates on the surface of the collagen I 
fibrils, which would be favoured at high 
concentrations of collagen I, could also disfavor 
amyloid formation (see below) and contribute to the 
complex dose-dependent behavior observed. 
 
Role of the collagen sequence and conformation 
in LMW-heparin-induced aggregation of WT-
Kȕ2m 
Collagen I can adopt a hierarchy of structures 
within the ECM (Figure 2A). The canonical 
collagenous sequence consists of Gly-Xaa-Yaa 
triplets, where Xaa and Yaa can be any amino acid, 
but are most often Pro and hydroxyproline (Hyp/O), 
respectively. Single collagen polypeptide chains 
fold into polyproline type II (PPII) helices. Three 
such chains then twist together to form a triple helix 
that is stabilized by a network of inter-chain 
hydrogen bonds between Gly and Xaa of a 
neighboring chain(35). The triple helices further 
self-assemble into higher order fibrils. To 
determine the effects of collagen sequence and 
conformation on the aggregation kinetics of WT-
Kȕ2m, the kinetics of LMW-heparin-induced 
aggregation were monitored in the presence of two 
different collagen mimetic peptides (CMPs), as 
well as denatured full-length collagen I. The CMP, 
Ac-(Pro-Hyp-Gly)10-GY-NH2 (named POG10), 
forms a stable triple helix conformation without 
additional native sequence fragments(36). 
However, this peptide does not form intermolecular 
interactions required to proceed to collagen fibril 
formation. Removal of only one Gly from the 
middle POG repeat (named Gly-), disrupts the triple 
helix conformation(37,38). By contrast with the 
complex effects of collagen I fibrils on the lag time 
of LMW-heparin induced aggregation of WT-Kȕ2m 
(Figure 1E), incubation of WT-Kȕ2m monomers 
(0.47 mg/ml) with up to 1 mg/ml POG10 or Gly- 
peptide, in the presence of 0.1 mg/ml LMW-heparin 
did not significantly affect the lag time of fibril 
formation relative to the lag time in the absence of 
peptide (Figure 2B,D,E, and Figure S1A,B,D). 
Full-length collagen I denatured into single chains 
also had no significant effect on the lag time of 
aggregation (Figure 2C, E and Figure S1C). Hence, 
adoption of a triple helical collagen structure with a 
native sequence is required for collagen I to 
modulate the rate of LMW-heparin-induced WT-
Kȕ2m aggregation, highlighting the specificity 
between the different surfaces involved in amyloid 
assembly.   
 
Surface-mediated aggregation of WT-Kȕ2m is 
protected by collagen I 
To determine whether a stable complex is 
formed between WT-Kȕ2m monomer and/or fibrils 
and collagen I, samples were taken at different 
times during aggregation in the presence or absence 
of 0.1 mg/ml LMW-heparin, added to collagen I 
(1.0 mg/ml) and pelleted 10 mins later by 
centrifugation at 5000 xg (Experimental 
Procedures). At this low centrifugation speed only 
collagen I fibrils sediment, while WT-Kȕ2m 
(monomers, oligomers and fibrils) remain in the 
supernatant. Whether WT-Kȕ2m monomers/small 
oligomers and/or fibrils bind collagen I was then 
determined by monitoring the band intensity of 
WT-Kȕ2m that pelleted with collagen I on an SDS-
PAGE gel. These experiments showed that WT-
Kȕ2m co-precipitates with collagen I fibrils only 
after an incubation time of 35 h (Figure 3A-C), (ca. 
the t50 of aggregation in the presence of 0.1 mg/ml 
LMH-heparin (Figure 1A)). A higher extent of co-
precipitation was observed after 85 h, by which 
time WT-hȕ2m amyloid formation has reached 
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completion in the presence of LMW-heparin 
(Figures 1A and 3A,C). These results show that the 
fibrillar form of WT-Kȕ2m interacts with collagen I 
fibrils most tightly, while species formed in the lag 
time appear not to bind collagen I tightly, at least at 
the detection limit of these experiments. Consistent 
with these results, interactions between WT-Kȕ2m 
monomers and LMW-heparin or collagen I were 
found to be weak as assessed by 1H-15N HSQC 
NMR spectra. This was assessed by 1 h co-
incubation of 80 PM 15N-WT-Kȕ2m with 0.2 mg/ml 
LMW-heparin and/or 2 mg/ml collagen I and 
measurement of the chemical shifts of backbone 
resonances. No significant chemical shift 
perturbations (or linewidth) were observed in these 
experiments (Figure S2), suggesting that these 
interactions are too weak to detect by these methods 
under the conditions employed.  
Since WT-Kȕ2m fibrils and collagen I were 
shown to interact by the co-pelleting assay, we next 
analysed the effect of collagen I on seeded growth 
of WT-Kȕ2m fibrils (using WT-Kȕ2m fibril seeds 
produced in the presence of LMW-heparin 
(Experimental Procedures)). As expected, the 
addition of WT-Kȕ2m seeds (5-30 % v/v) enhances 
the rate of formation of WT-Kȕ2m fibrils, dependent 
on the seed concentration (Figure 4A). Note that 
under these quiescent conditions and without seeds 
no fibrils form(22,24,26). Interestingly, a biphasic 
curve is generated in the presence of fibril seeds, 
with the first (relatively small) increase in ThT 
fluorescence intensity occurring in the first 2 h 
(Figure 4A and inset). This phase presumably 
monitors the elongation of fibril ends by WT-Kȕ2m 
monomers. Addition of 1 mg/ml collagen I does not 
affect this phase (Figure 4B). By contrast, the 
second phase, with larger ThT amplitude (Figure 
4A), is significantly retarded by the addition of 1 
mg/ml collagen I (Figure 4B, Figure S3). In the 
presence of low concentrations (5 % v/v) of seeds 
and under quiescent conditions, these fibril-
mediated interactions are the dominant processes of 
fibril formation. Hence, in these conditions, the 
interaction of collagen I with WT-Kȕ2m fibrils, 
observed by co-precipitation (Figure 3A), protects 
against fibril surface-mediated growth of WT-hE2m 
amyloid by masking the fibril surface.  
The specificity of collagen I for WT-hE2m 
fibrils was next probed by monitoring the effect of 
collagen I on reactions in which pre-formed seeds 
of 'N6-hE2m were used to cross-seed amyloid 
formation of WT-hE2m monomers (Figure 4C,D). 
WT-hE2m and ǻȃ-hE2m are known to co-
aggregate(13,18,23), forming fibrils of a different 
morphology in vitro than those formed by each 
protein alone(27). The results showed that the effect 
of collagen I on the seeded aggregation of WT-
hE2m is highly dependent on the identity of the 
seeds added. Addition of ǻȃ-hE2m seeds to WT-
hE2m monomers also results in biphasic fibril 
growth curves (Figure 4C). However, the rate of the 
initial phase is slower under all conditions for the 
cross-seeded reactions compared with the self-
seeded reactions (Figure S3A). Most notably, the 
secondary process, that occurs after rapid fibril 
elongation, is much less affected by collagen I in 
the cross-seeded reactions than when self-seeded 
(compare Figures 4 B and D, see also Figure S3B). 
Thus, the interference of collagen I with surface-
mediated growth of WT-hE2m fibrils depends on 
the morphology of the hE2m fibril seeds which 
differ when self-seeded and cross-VHHGHGE\ǻȃ-
hE2m(27).  
 
LMW-heparin promotes assembly of WT-hE2m 
fibrils in both self-seeded and cross-seeded 
reactions 
Finally, the effect of LMW-heparin on fibril 
formation of WT-hE2m was monitored in seeded 
reactions, to determine whether the addition of this 
GAG can out-compete the effect of collagen I on 
aggregation. When mixed, LMW-heparin is able to 
rescue the inhibitory effect of collagen I on 
secondary processes whether the reaction is self- or 
cross-seeded (Figures 5A-D and Figure S3). Thus, 
collagen I and LMW-heparin have different effects 
on WT-hE2m aggregation at multiple phases of 
fibrillation. Collagen I acts primarily on the 
secondary surface-mediated growth of self-seeded 
fibrils and is dependent on whether the reaction is 
self- seeded or cross-seeded (compare Figures 4A,B 
with 5A,B)). By contrast, LMW-heparin can 
enhance growth at all stages of aggregation and is 
insensitive to the distinct amyloid conformations 
produced by self-seeding or cross-seeding with 
'N6-hE2m. 
 
DISCUSSION 
A detailed study of the effects of the local 
environment on the course of protein aggregation is 
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important for understanding how amyloid 
formation may be initiated and substantiated in 
vivo. Previous studies have shown the effects of 
chaperones(39-41), metal ions(19,32,42), 
membranes(43), trifluoroethanol or SDS co-
solvents(28,29,44), GAGs(18,30,45,46) and other 
natural compounds(13,17,47) on the formation of 
amyloid fibrils in vitro. For some of these 
compounds, detailed kinetic analysis has revealed 
the effect of each reagent on the different kinetic 
steps in aggregation, including primary nucleation, 
elongation from fibril ends, and secondary 
processes such as fibril fragmentation and 
secondary nucleation(39-41,43,48). Such studies 
can provide important information on the role of 
biologically-relevant and other compounds on 
amyloid formation, including how the different 
factors may act synergistically to alter the course of 
aggregation in an in vitro setting(17,30). 
Here we have adopted this approach by 
examining the effects of two macromolecules that 
are present in conditions relevant to DRA, collagen 
I and the GAG LMW-heparin. Since WT-hE2m is 
not prone to amyloid formation in the absence of 
co-factors at pathophysiological pH and 
temperature, understanding how the molecular 
components of the local environment affect WT-
hE2m amyloid formation and impact the kinetics of 
fibril formation is important for developing an 
understanding of hE2m amyloidogenesis in DRA. In 
addition, how the biological environment affects 
the ability of 'N6-hE2m, which makes up ~30% of 
the hE2m component in DRA plaques(21,23), to 
stimulate aggregation of WT-Kȕ2m may also shed 
light on how the aggregation of WT-Kȕ2m may be 
initiated in vivo.  
Understanding amyloid formation of WT-
hE2m in mechanistic detail in the context of the 
ECM in joints and cartilage is extremely 
challenging, given the multi-component 
composition it presents. Here, we have started to 
investigate aggregation in this environment by 
determining how different components relevant to 
DRA (collagen I and LMW-heparin) impact the 
different kinetic stages of WT-hE2m aggregation. 
The studies presented show that LMW-heparin, 
collagen I and 'N6-hE2m have different effects on 
the course of WT-hE2m aggregation, which 
compete for the different stages of aggregate 
formation. Firstly, under all conditions, LMW-
heparin is able to promote the self-assembly of WT-
hE2m, decreasing the lag time and increasing the 
rate of fibril formation by affecting secondary 
stages, whether self-seeded or cross-seeded by 
'N6-hE2m. Previous studies have shown that 
LMW-heparin binds and stabilizes WT-hE2m 
amyloid fibrils, while the non-sulfated GAG 
hyaluronic acid has no effect on fibril stability or 
the rate of fibril formation, suggesting that ionic 
interactions between the GAG and WT-hE2m must 
be involved(17). Determining the origins of 
molecular recognition between different species 
(monomers, oligomers and fibrils) of WT-hE2m and 
'N6-E2m and GAGs will require further 
exploration, for example by varying the patterns of 
sulfation, the identity of the carbohydrate moieties 
that differ between GAGs, and the length of the 
GAG, which have been shown previously to affect 
amyloid-GAG recognition(49,50). Analysis of the 
effects of heparan sulfate, the most abundant GAG 
in the joint ECM, would be particularly important 
for hE2m, although previous studies have shown 
that heparan sulfate and LMW-heparin have similar 
effects on seeded elongation of fibril growth using 
WT-hE2m(17).  
By contrast with LMW-heparin, collagen I has 
a more complex role on WT-hE2m assembly into 
amyloid, affecting the lag time of fibril formation 
and secondary growth phases in different ways, 
dependent on the concentration added, the presence 
of LMW-heparin, the structural organization of the 
collagen added and whether fibril growth WT-hE2m 
is self-seeded or cross-seeded by 'N6-hE2m fibrils. 
A decrease in the lag time of WT-hE2m assembly 
occurs upon addition of low concentrations of 
collagen I and LMW-heparin relative to the 
addition of LMW-heparin alone, suggestive of one 
route for the initiation of WT-hE2m assembly at 
pathophysiological pH and temperature. However, 
at high concentrations of collagen I the lag time is 
extended. Collagen I fibrils also interact strongly 
with WT-hE2m amyloid fibrils suppressing surface 
mediated growth (Figure 6, top) by competing for 
interactions with the WT-hE2m fibril surface. 
Notably, a different fibril morphology formed by 
cross-seeding WT-hE2m with 'N6-hE2m fibrils, 
does not show this marked suppression of fibril 
formation by collagen I (Figure 6, bottom). 
Whether self-seeded or cross-seeded with 'N6 
fibril seeds, LMW-heparin is able to outcompete 
Extracellular matrix modulates E2m amyloid formation 
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the binding of collagen I to WT-hE2m fibrils, 
releasing the potential of the amyloid fibril surface 
to enhance fibril formation via secondary 
nucleation processes. These results are consistent 
with previous studies that also showed enhanced 
aggregation of WT-hE2m in the presence of LMW-
heparin(18,24). In addition to its role in suppressing 
amyloid formation, interactions between collagen I 
and WT-hE2m fibrils may prevent the clearance of 
amyloid from the joint space, providing an 
explanation for the localization of DRA plaques to 
joint and cartilage tissues. Other factors not 
investigated here, such as the presence of 
chaperones and/or other proteins, oxidation, 
glycation, or other post-translational modifications 
of the hE2m sequence, the presence of Cu2+ ions, 
and shear flow within the joint space may also 
contribute to amyloid 
formation(17,19,31,40,51,52). Overall, therefore, 
the results portray a marked complexity in amyloid 
formation in the ECM, in which a finely tuned 
balance of different components (in this case 
collagen I, LMW-heparin and 'N6-hE2m) affect the 
progression of hE2m aggregation and its 
sequestration in the joints to give a pattern of 
amyloid deposition that is the hallmark of DRA.  
 
EXPERIMENTAL PROCEDURES 
 
Protein preparation 
WT-Kȕ2PDQGǻ1-Kȕ2m were expressed and 
purified as described previously(22). For NMR 
experiments, 15N- and 13C-labelled WT-Kȕ2m and 
ǻ1Kȕ2m were prepared as described in(53).  
 
Collagen preparation 
Collagen type I (354249) from rat tail was 
purchased from BD Biosciences. Collagen was 
diluted to 3 mg/ml in 0.1 M acetic acid. Before use, 
it was dialysed into 50 mM MES, 120 mM NaCl at 
pH 6.2. For preparation of collagen I fibrils, the 
dialyzed collagen was incubated at 37 ƕC for 1 h. 
For preparation of collagen single chains, the 
dialyzed collagen was incubated for 30 min at 70 
ƕC. CMPs POG10 and Gly-, were purchased from 
LifeTein and Tufts University Core facility, 
respectively, and were directly diluted into 50 mM 
MES, 120mM NaCl at pH 6.2 to the concentrations 
specified. 
 
Formation of fibril seeds 
Fibrils of WT-Kȕ2m were assembled in 50 mM 
MES buffer, 120 mM NaCl at pH 6.2 in the 
presence of 0.1 mg/ml LMW-heparin (Iduron) in a 
BMG Fluostar Optima plate reader at 37 °C at 600 
rpm. The fibrils were sonicated for 1 min, 
distributed in aliquots and frozen in liquid nitrogen. 
The size of the seeds was determined using negative 
stain transmission electron microscopy (TEM).  
  
Kinetic measurement of aggregation 
WT-Kȕ2P DQG ǻ1-Kȕ2m fibrils were 
assembled in 50 mM MES buffer, 120 mM NaCl at 
pH 6.2. Fibril growth was performed in a BMG 
Fluostar Optima plate reader at 37 °C at 600 rpm (or 
quiescently in the case of seeded reactions). A final 
FRQFHQWUDWLRQRIȝ07K76LJPD DQGPM 
E2m was used. When required, seeds (5-30 % v/v) 
were added. The fibril yield was measured by 
centrifuging 50 µl of the end points at 14000g, 
where amyloid fibrils are found in the pellet and 
soluble material remains in the supernatant and can 
be quantified spectrophotometrically.  
 
Determination of the lag time of fibril growth 
The lag times of fibril growth under different 
conditions were determined by fitting a tangent to 
the curve at the midpoint of the elongation phase 
and extrapolating this time to the baseline signal in 
the lag phase. The intersection point of these two 
lines was considered the lag time. 
 
Determination of the elongation rate and the half 
time of kinetics in the presence of seeds 
ThT fluorescence curves were normalized to 
the final time point where ~100% of the protein was 
converted to fibrils. In cases where this was not the 
case, and therefore there was no plateau in the 
fluorescence curves (such as in Figures 4B and 4D), 
the ThT signal was normalized to the corresponding 
value in the presence of LMW-heparin (Figures 5B, 
5D) where the fibril yield was 100%. The observed 
elongation rate was calculated by fitting straight 
lines to the ThT fluorescence curves in the first hour 
of the normalized aggregation kinetics divided by 
the concentration of seeds. The t50 is the time taken 
to reach 50% of the maximal ThT fluorescence. 
 
Collagen co-precipitation 
40 µM WT-Kȕ2m (in the presence/absence of 
0.1 mg/ml LMW-heparin) was incubated at 37 °C 
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at 600 rpm in a BMG Fluostar Optima plate reader. 
At different time points, 40 Pl aliquots were taken 
and mixed with 1 mg/ml of collagen I fibrils and 
incubated for 10 mins. The sample was centrifuged 
at 5000 xg for 10 min. Samples in the absence of 
LMW-heparin were used as a control. The pellet 
was washed once with the incubation buffer and the 
centrifugation step was repeated. The pellet and the 
supernatant were then separately analyzed using 
15% (w/v) polyacrylamide Tris-Tricine gels. Gels 
were stained with Coomassie Instant Blue 
(Expedeon).  
 
NMR spectroscopy 
Samples of 15N-labeled protein (40-ȝ0LQ
50 mM MES buffer containing 120 mM NaCl, pH 
6.2 90% (v/v) H2O/10% (v/v) D2O were used for 
NMR experiments. 1H-15N HSQC spectra were 
collected in a Varian INOVA NMR spectrometer 
performing at 600 MHz and were processed in 
NMRPipe and analyzed using programmes 
available in CCPNMR analysis(54,55). 
 
Electron microscopy 
At the end of ILEULODVVHPEO\ȝORIVDPSOH
were applied to carbon-coated EM grids. The grids 
were then carefully dried with filter paper before 
samples were negatively stained by the addition of 
ȝORIZYXUDQ\ODFHWDWH0LFURJUDSKVZHUH
recorded on a JEOL JEM-1400 electron 
microscope.  
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FOOTNOTES 
1
 The abbreviations used are: Kȕ2mKXPDQȕ2-microglobulin; DRA, Dialysis related amyloidosis; ECM, 
extracellular matrix; ThT, thioflavin T; MHC I, major histocompatibility complex class I; GAG, 
glycosaminoglycan; LMW, low molecular weight; CMP, collagen mimetic peptide; TEM, transmission 
electron microscopy 
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Figures and Figure Legends 
 
Figure 1 
 
 
 
 
 
 
 
Figure 1. (A) Amyloid fibril formation of WT-hȕ2m (40PM) in the absence (purple) or presence 
(blue) of 0.1 mg/ml LMW-heparin. (B) Negative stain transmission electron micrograph (TEM) at 
the end of the aggregation reaction (80 h) for WT-hȕ2m in the presence of 0.1 mg/ml LMW-heparin. 
(C) Effect of collagen I on WT-hȕ2m aggregation in the absence of LMW-heparin. Collagen I 
concentrations are indicated in the panel in mg/ml. (D) Negative stain TEM of the sample at 1 
mg/ml collagen after 80 h of incubation. (E) Effect of collagen I on WT-hȕ2m aggregation in the 
presence of 0.1 mg/ml LMW-heparin. For each condition, a single ThT fluorescence trace 
F 
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representative of the mean aggregation kinetics taken over at least three replicate experiments, with 
three samples in each is shown (see also Figure S1). (F) Representative negative stain TEM of the 
end point of the aggregation process in the presence of 1 mg/ml collagen I and 0.1 mg/ml LMW-
heparin. Scale bar in all TEM panels = 100 nm. Note the schematic drawings used to annotate the 
different reagents present in different experiments (WT-hȕ2m (purple), LMW-heparin (grey) and 
collagen I fibrils (yellow/red bundle)). These symbols are used throughout the manuscript to denote 
the additives included in each experiment.   
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Figure 2 
 
 
Figure 2: The effect of CMPs and denatured collagen chains on LMW-heparin-induced WT-Kȕ2m fibril 
formation. (A) Schematic of collagen hierarchical conformations, from the primary amino acid sequence, 
single chain PPII helix, triple helix of three single chains, and higher order fibrils. LMW-heparin-induced 
aggregation kinetics of WT-Kȕ2m (40PM) in the presence of (B) POG10 peptide (which forms a stable 
collagen triple helix), (C) collagen I in the single chain form, and (D) Gly- peptide (that does not form a 
stable triple helix). The concentration of the peptides added is indicated by color in the inset. All traces 
were obtained with 0.1 mg/ml LMW-heparin. Negative stain TEM micrographs of the end points are shown 
as an inset for each condition (scale bar = 100 nm). (E) Box plot of the lag time for the WT-Kȕ2m 
aggregation in the presence or absence of 1 mg/ml collagen I fibrils (data taken from Figure 1E), denatured 
collagen, or CMPs. WT (WT-hE2m alone (no collagen or CMPs added)), Fibril (WT-hE2m plus collagen I 
fibrils); POG (WT-hE2m plus POG10 peptide), SC (WT-hE2m plus single chain collagen I), Gly- (WT-hE2m 
plus Gly-peptide). The data are representative of three replicate experiments, with three samples in each. 
Asterisk denotes p<0.002. 
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Figure 3 
 
 
 
Figure 3. (A) Co-pelleting of WT-hE2m aggregated for different times with collagen I fibrils with/without 
0.1 mg/ml LMW-heparin. SDS PAGE analysis of the whole sample (w) and the pellet after sedimentation 
of collagen I by low speed centrifugation (p). Molecular weight markers with masses in kDa are shown 
alongside. (B) Negative stain TEM micrograph of WT-hE2m incubated in the presence of 1.0 mg/ml 
collagen I and 0.1 mg/ml LMW-heparin for 15 h, showing the presence of collagen I fibrils but no WT-
hE2m amyloid. (C), as (B) but image taken after incubation for 65 h. WT-hE2m amyloid can be clearly seen 
in this image alongside collagen I fibrils. Scale bar in each micrograph is 500 nm.  
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Figure 4 
 
 
 
 
Figure 4: The effect of collagen I fibrils on self-seeded and cross-seeded growth with WT-hȕ2m monomers. 
(A) Aggregation kinetics of WT-hȕ2m in the presence of preformed WT-hȕ2m seeds (5-30% (v/v)). The 
inset shows an expanded plot over the first ~ 2 hours. (B) As in (A), but in the presence of 1 mg/ml collagen 
I. (C) Aggregation kinetics of WT-hȕ2m in the presence of preformed ¨1-hȕ2m seeds (5-30% (v/v)). The 
inset shows an expanded plot over the first ~ 2 hours. (D) As in (C), but upon addition of 1 mg/ml of 
collagen I. Three replicate experiments, with three samples in each were measured. Here, a single trace 
representative of the mean aggregation kinetics is shown. See also Figure S3 for statistics. 
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Figure 5 
 
 
 
Figure 5: The effect of LMW-heparin on self-seeded and cross-seeded growth with WT-hȕ2m monomers. 
(A) Aggregation kinetics of WT-hȕ2m in the presence of preformed WT-hȕ2m seeds (5-30% (v/v)) and 0.1 
mg/ml LMW-heparin. The inset shows an expansion of the first ~ 2h. (B) As in (A), but in the presence of 
0.1 mg/ml LMW-heparin and 1 mg/ml collagen I. (C) Aggregation kinetics of WT-hȕ2m in the presence of 
preformed ¨1-hȕ2m seeds (5-30% (v/v)) in the presence of 0.1 mg/ml LMW-heparin. The inset shows an 
expansion of the first ~ 2h. (D) As in (C), but in the presence of 0.1 mg/ml LMW-heparin and 1 mg/ml 
collagen I. Three replicate experiments, with three samples in each were acquired. See also Figure S3.  
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Figure 6 
 
 
Figure 6: Schematic of the effect of ECM components on seeded WT-hȕ2m aggregation. (Top) WT-hȕ2m 
forms amyloid through self-seeded fibril growth. A secondary phase, fibril surface mediated growth, is 
enhanced by LMW-heparin and a co-mixture of LMW-heparin and collagen I, but is suppressed by collagen 
alone. (Bottom) Cross-seeding WT-hȕ2m monomer with ¨1-hȕ2m seeds forms fibrils with a different 
conformation(27). The fibril surface mediated growth of these fibrils is also enhanced by LMW-heparin 
and the LMW-heparin and collagen I co-mixture, but is not affected by collagen I alone. 
 
